2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
4
Glioblastoma
3
Esophageal Neoplasms
3
Recurrence
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Brain Neoplasms
2
Thyroid Neoplasms
1
Pathologic Complete Response
1
Oligodendroglioma
1
Lymphoma, Follicular
1
Lymphatic Metastasis
1
Li-Fraumeni Syndrome
1
Gliosarcoma
1
Glioma
1
Ependymoma
1
Disease
1
DWI-MRI
1
Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Astrocytoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Fluorouracil
67
Radiotherapy
53
Cisplatin
52
Oxaliplatin
47
Leucovorin
37
Paclitaxel
36
Irinotecan
27
Docetaxel
23
Capecitabine
20
Nivolumab
17
Carboplatin
16
pembrolizumab
15
Radiation
15
Neoadjuvant Therapy
15
Surgical Procedures, Operative
12
Cetuximab
12
durvalumab
9
Drug Therapy
9
Biopsy
9
Taxes
8
Folfox protocol
8
Chemotherapy, Adjuvant
8
Trastuzumab
7
Magnetic Resonance Spectroscopy
7
Gefitinib
7
Endoscopy
7
tremelimumab
6
Specimen Handling
6
Endoscopy, Digestive System
6
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Diffusion Magnetic Resonance Imaging
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled